Soluble forms of P-, E- and L-selectin in children with Kawasaki disease

Kurume Medical Journal

Volumn 48, Issue 2, 2001, Pages 135-143

  Furui, Jun ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell adhesion molecules; Coronary artery lesion; High dose intravenous immunoglobulin theraphy; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; L SELECTIN; PADGEM PROTEIN;

ARTICLE; CHILDHOOD DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMA; PRESCHOOL CHILD; VASCULITIS;

EID: 0034866015     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.48.135     Document Type: Article

References (30)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy 1967; 16:178-222. (in Japanese)
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, and Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54:271-276.
3. Kato H, Koike S, Yamamoto M, Ito Y, and Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr 1975; 86:892-898.
4. The Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Diagnostic guidelines for Kawasaki disease. Am J Dis Child 1990; 144:1218-1219.
5. Kato H, Koike S, and Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979; 63:175-179.
6. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 1982; 49:1758-1766.
7. Kato H, Sugimura T, Akagi T, Sato N, Hashino K et al. Long-term consequences of Kawasaki disease: a 10 - to 21 year follow-up study of 594 patients. Circulation 1996; 94:1379-1385.
8. Kato H, Ichinose E, and Kawasaki T. Myocardial infarction in Kawasaki disease: Clinical analyses in 195 cases. J Pediatr 1986; 108:923-927.
9. Kato H, Inoue O, and Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev 1988; 9:209-217.
10. Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G et al. Coronary endothelium dysfunction after Kawasaki disease: Evaluation by intracoronary injection of acetylcholine. J Am Coll Caridol 1998; 31:1074-1108.
11. Iemura M, Ishii M, Sugimura T, Akagi T, and Kato H. Long-term consequences of regressed coronary aneurysms after Kawasaki Disease: vascular wall morphology and function. Heart 2000; 83:307-311.
12. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K et al. High-dose intravenous gamma globulin for Kawasaki disease. Lancet 1984; 2:1055-1058.
13. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315:341-347.
14. Hashino K, Ishii M, lemura M, Akagi T, and Kato H. Retreatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int (in press)
15. Sato N, Sugimura T, Akagi T, Yamakawa R, and Hashino K. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness. Pediatr Int 1999; 41:1-7.
16. Tedder TF, Steeber DA, Chen A, and Engel P. The selectins: vascular adhesion molecules. FASEB J 1995; 9:866-873.
17. Gearing AJH, and Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14:506-512.
18. Timothy M, and Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-2101.
19. Kansas GS. Selectins and their ligands: Current concepts and controversies. Blood 1996; 88:3259-3287.
20. Kim DS, and Lee KY. Serum soluble E-selectin levels in Kawasaki disease. Scand J Rheumatol 1994; 23:283-286.
21. Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H et al. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997; 108:446-450.
22. Schiller B, and Elinder G. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment. Acta Paediatr 1999; 88:844-848.
23. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92:1693-1696.
24. Yamashita N, Kaneko S, Kouro O, Furue M, Yamamoto S et al. Soluble E-selectin as a marker of disease activity in atopic dermatitis. J Allergy Clin Immunol 1997; 99:410-416.
25. Bagnato G, Gulli S, Altavilla D, Squadrito F, Giacobbe O et al. Circulating adhesion molecules in bronchial asthma. J Investig Allergol Clin Immunol 1998; 8:105-108.
26. Kourtis AP, Nesheim SR, Thea D, Ibegbu C, Nahmias AJ et al. Correlation of virus load and soluble L-selectin, a marker of immune activation, in pediatric HIV-1 infection. AIDS 2000; 14:2429-2436.
27. Pigott R, Dillon LP, Hemingway IH, and Gearing AJ. Soluble forms E-selectin, ICAM-1 and VCAM-1 are present in the supernatants cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187:584-589.
28. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW et al. Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil mediated lung injury in rats. J Clin Invest 1991; 88:1396-1406.
29. Ohnishi M, Imanishi N, and Tojo SJ. Protective effect of anti-P-selectin monoclonal antibody in lipopolysaccharide-induced lung hemorrhage. Inflammation 1999; 23:461-469.
30. Schlag G, Redl HR, Till GO, Davies J, Martin V et al. Anti-L-selectin antibody treatment of hemorrhagic-traumatic shock in baboons. Crit Care Med 1999; 27:1900-1907.